BrainStorm Cell Therapeutics
BCLI
#10936
Rank
HK$83.08 M
Marketcap
HK$7.53
Share price
6.67%
Change (1 day)
48.96%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -HK$4.62

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$8.39. In 2022 the company made an earnings per share (EPS) of -HK$5.18 an increase over its 2021 EPS that were of -HK$5.33.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$4.62-10.66%
2022-HK$5.18-2.94%
2021-HK$5.33-37.04%
2020-HK$8.471.89%
2019-HK$8.3151.43%
2018-HK$5.49159.26%
2017-HK$2.12-3.57%
2016-HK$2.20-37.78%
2015-HK$3.53-33.82%
2014-HK$5.3336%
2013-HK$3.9211.11%
2012-HK$3.5350%
2011-HK$2.35-50%
2010-HK$4.71-233.33%
2009HK$3.53-142.86%
2008-HK$8.24-65%
2007-HK$23.53
2005HK$7.76-108.03%
2004-HK$96.7413203.07%
2003-HK$0.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
HK$18.51-320.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$24.31 189.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-HK$31.45 274.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-HK$56.63 574.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$15.84-288.79%๐Ÿ‡บ๐Ÿ‡ธ USA